Literature DB >> 12045670

Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of s-100beta in the periinfarct area precedes delayed infarct expansion.

Toru Matsui1, Takashi Mori, Narito Tateishi, Yoshifumi Kagamiishi, Souichi Satoh, Nobuo Katsube, Eiharu Morikawa, Tadashi Morimoto, Fusahiro Ikuta, Takao Asano.   

Abstract

An astrocytic protein S-100beta enhances the expression of inducible nitric oxide synthase in cultured astrocytes at micromolar concentrations, leading to nitric oxide-mediated death of cocultured neurons. The present study examined whether S-100beta production by reactive astrocytes accumulating within the periinfarct area was related to delayed expansion of infarct volume after permanent middle cerebral artery occlusion in the rat. After rapid increases during the initial 24 hours, the increase of infarct volume then decelerated while maintaining the increasing tendency until 168 hours in this model, attaining a significant difference compared with that at 24 hours. In the periinfarct area, the number of reactive astrocytes expressing both S-100 and glial fibrillary acidic protein, the tissue level of S-100beta as measured by the sandwich enzyme-linked immunosolvent assay method using anti-S-100beta monoclonal antibody, and the number of terminal deoxynucleotidyl transferase-mediated 2;-deoxyuridine 5;-triphosphate-biotin nick end labeling-positive cells were significantly increased preceding the delayed expansion of infarct volume. The CSF concentration of S-100beta showed a biphasic increase, presumably reflecting the immediate release from astrocytes within the ischemic core and the subsequent production in reactive astrocytes within the periinfarct area. These results show for the first time that the enhanced synthesis of S-100beta by reactive astrocytes participates in the inflammatory responses within the periinfarct area, which may be related to the occurrence of delayed infarct expansion as a major component of the cytokine network.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045670     DOI: 10.1097/00004647-200206000-00010

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  31 in total

1.  Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.

Authors:  Le Wu; Sen Miao; Lin-Bing Zou; Ping Wu; Hua Hao; Ke Tang; Pan Zeng; Jing Xiong; Hong-Hua Li; Qiang Wu; Lei Cai; Du-Yun Ye
Journal:  J Mol Neurosci       Date:  2012-06-03       Impact factor: 3.444

Review 2.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

3.  Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.

Authors:  T Himeda; Y Watanabe; H Tounai; N Hayakawa; H Kato; T Araki
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

4.  S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.

Authors:  Roberta Bianchi; Eirini Kastrisianaki; Ileana Giambanco; Rosario Donato
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

5.  Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways.

Authors:  Pratap Karki; Peter Hong; James Johnson; Edward Pajarillo; Deok-Soo Son; Michael Aschner; Eunsook Y Lee
Journal:  Mol Neurobiol       Date:  2017-08-15       Impact factor: 5.590

6.  Temporal profiles of aquaporin 4 expression and astrocyte response in the process of brain damage in fat embolism model in rats.

Authors:  Toru Gohara; Kazuyoshi Ishida; Kazuhiko Nakakimura; Mitsuyoshi Yoshida; Shiro Fukuda; Mishiya Matsumoto; Takefumi Sakabe
Journal:  J Anesth       Date:  2010-01-29       Impact factor: 2.078

7.  Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia.

Authors:  Takashi Mori; Jun Tan; Gary W Arendash; Naoki Koyama; Yoshiko Nojima; Terrence Town
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

8.  Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice.

Authors:  Chie Oki; Yu Watanabe; Hironori Yokoyama; Taiji Shimoda; Hiroyuki Kato; Tsutomu Araki
Journal:  Cell Mol Neurobiol       Date:  2008-01-17       Impact factor: 5.046

9.  Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Takashi Mori; Naoki Koyama; Gary W Arendash; Yuko Horikoshi-Sakuraba; Jun Tan; Terrence Town
Journal:  Glia       Date:  2010-02       Impact factor: 7.452

10.  Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid- (ONO-2506) treated stroke-prone spontaneously hypertensive rats.

Authors:  Hideaki Higashino; Atsuko Niwa; Takao Satou; Yoshio Ohta; Shigeo Hashimoto; Masaki Tabuchi; Kana Ooshima
Journal:  J Neural Transm (Vienna)       Date:  2009-08-06       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.